196
Views
55
CrossRef citations to date
0
Altmetric
Article

Mutational activation of the RAS‐RAF‐MAPK and the wnt pathway in small intestinal adenocarcinomas

, , , , , & show all
Pages 748-753 | Received 20 Aug 2003, Accepted 02 Mar 2004, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Namood-e Sahar, Javeria Qadir, Syeda Kiran Riaz, Aimen Sultan, Aiza Arif & Muhammad Faraz Arshad Malik. (2022) Dysregulation of core circadian genes, BMAL1 and CLOCK, in colorectal cancer. Biological Rhythm Research 53:9, pages 1400-1413.
Read now
Alejandro Schcolnik-Cabrera, Alma Chávez-Blanco, Guadalupe Domínguez-Gómez, Lucia Taja-Chayeb, Rocio Morales-Barcenas, Catalina Trejo-Becerril, Enrique Perez-Cardenas, Aurora Gonzalez-Fierro & Alfonso Dueñas-González. (2018) Orlistat as a FASN inhibitor and multitargeted agent for cancer therapy. Expert Opinion on Investigational Drugs 27:5, pages 475-489.
Read now
Gustaw Lech, Wojciech Korcz, Emilia Kowalczyk, Robert Słotwiński & Maciej Słodkowski. (2017) Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome. Scandinavian Journal of Gastroenterology 52:11, pages 1194-1202.
Read now

Articles from other publishers (52)

Jan Moritz Niehues, Philip Quirke, Nicholas P. West, Heike I. Grabsch, Marko van Treeck, Yoni Schirris, Gregory P. Veldhuizen, Gordon G.A. Hutchins, Susan D. Richman, Sebastian Foersch, Titus J. Brinker, Junya Fukuoka, Andrey Bychkov, Wataru Uegami, Daniel Truhn, Hermann Brenner, Alexander Brobeil, Michael Hoffmeister & Jakob Nikolas Kather. (2023) Generalizable biomarker prediction from cancer pathology slides with self-supervised deep learning: A retrospective multi-centric study. Cell Reports Medicine 4:4, pages 100980.
Crossref
Atsushi Tatsuguchi, Takeshi Yamada, Koji Ueda, Hiroyasu Furuki, Aitoshi Hoshimoto, Takayoshi Nishimoto, Jun Omori, Naohiko Akimoto, Katya Gudis, Shu Tanaka, Shunji Fujimori, Akira Shimizu & Katsuhiko Iwakiri. (2022) Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing. BMC Cancer 22:1.
Crossref
Abdulhameed Alfagih, Mohammad Alrehaili & Timothy Asmis. (2022) Small Bowel Adenocarcinoma: 10-Year Experience in a Cancer Center—The Ottawa Hospital (TOH). Current Oncology 29:10, pages 7439-7449.
Crossref
Karan Pandya, Michael J. Overman & Pat Gulhati. (2022) Molecular Landscape of Small Bowel Adenocarcinoma. Cancers 14:5, pages 1287.
Crossref
Wenli Liu, Hongzhen Li, Wulin Aerbajinai, Istvan Botos & Griffin P. Rodgers. (2021) OLFM4-RET fusion is an oncogenic driver in small intestine adenocarcinoma. Oncogene 41:1, pages 72-82.
Crossref
Anuradha Sekaran, Debdeep Dey, Angad Singh & Prasenjit Das. 2022. Surgical Pathology of the Gastrointestinal System. Surgical Pathology of the Gastrointestinal System 699 782 .
Filippo Pelizzaro, Ilaria Marsilio, Matteo Fassan, Francesco Piazza, Brigida Barberio, Anna D’Odorico, Edoardo V. Savarino, Fabio Farinati & Fabiana Zingone. (2021) The Risk of Malignancies in Celiac Disease—A Literature Review. Cancers 13:21, pages 5288.
Crossref
Katrina S. Pedersen, Nathan R. Foster, Michael J. Overman, Patrick M. Boland, Sunnie S. Kim, Kathryn A. Arrambide, Brandy L. Jaszewski, Tanios Bekaii-Saab, Rondell P. Graham, Jack Welch, Richard H. Wilson & Robert R. McWilliams. (2021) ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma. Clinical Cancer Research 27:13, pages 3641-3648.
Crossref
Alireza Tabibzadeh, Fahimeh Safarnezhad Tameshkel, Yousef Moradi, Saber Soltani, Maziar Moradi-Lakeh, G. Hossein Ashrafi, Nima Motamed, Farhad Zamani, Seyed Abbas Motevalian, Mahshid Panahi, Maryam Esghaei, Hossein Ajdarkosh, Alireza Mousavi-Jarrahi & Mohammad Hadi Karbalaie Niya. (2020) Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. Scientific Reports 10:1.
Crossref
Javier I Quezada‐Marín, Alfred K Lam, Atsushi Ochiai, Robert D Odze, Kay M Washington, Masashi Fukayama, Massimo Rugge, David S Klimstra, Iris D Nagtegaal, Puay‐Hoon Tan, Mark J Arends, John R Goldblum, Ian A Cree & Manuel Salto‐Tellez. (2020) Gastrointestinal tissue‐based molecular biomarkers: a practical categorisation based on the 2019 World Health Organization classification of epithelial digestive tumours. Histopathology 77:3, pages 340-350.
Crossref
Min Jia, Yan Zhang, Lina Jansen, Viola Walter, Dominic Edelmann, Melanie Gündert, Katrin E. Tagscherer, Wilfried Roth, Melanie Bewerunge-Hudler, Esther Herpel, Matthias Kloor, Alexis Ulrich, Barbara Burwinkel, Hendrik Bläker, Jenny Chang-Claude, Hermann Brenner & Michael Hoffmeister. (2019) A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival. Clinical Epigenetics 11:1.
Crossref
Basile Tessier-Cloutier, Ellen Cai & David F. Schaeffer. (2019) Off-label use of common predictive biomarkers in gastrointestinal malignancies: a critical appraisal. Diagnostic Pathology 14:1.
Crossref
Paolo Giuffrida, Alessandro Vanoli, Giovanni Arpa, Arturo Bonometti, Ombretta Luinetti, Enrico Solcia, Gino Corazza, Marco Paulli & Antonio Di Sabatino. (2018) Small Bowel Carcinomas Associated with Immune-Mediated Intestinal Disorders: The Current Knowledge. Cancers 11:1, pages 31.
Crossref
Ulrika A. Hänninen, Riku Katainen, Tomas Tanskanen, Roosa-Maria Plaketti, Riku Laine, Jiri Hamberg, Ari Ristimäki, Eero Pukkala, Minna Taipale, Jukka-Pekka Mecklin, Linda M. Forsström, Esa Pitkänen, Kimmo Palin, Niko Välimäki, Netta Mäkinen & Lauri A. Aaltonen. (2018) Exome-wide somatic mutation characterization of small bowel adenocarcinoma. PLOS Genetics 14:3, pages e1007200.
Crossref
Rachael A. Safyan & Alfred I. Neugut. (2018) Anti-EGFR Therapy in Small Bowel Adenocarcinoma. The Oncologist 23:3, pages 275-276.
Crossref
Kyung-Ju Kim, Jung Yeon Kim, Seung-Mo Hong & Mi Jin Gu. (2017) Loss of CADM4 expression is associated with poor prognosis in small intestinal adenocarcinomas. APMIS 125:5, pages 437-443.
Crossref
Kanwal Raghav, Matthew H. G. Katz & Michael J. Overman. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 416 428 .
Yu Nakaji, Eiji Oki, Ryota Nakanishi, Koji Ando, Masahiko Sugiyama, Yuichiro Nakashima, Nami Yamashita, Hiroshi Saeki, Yoshinao Oda & Yoshihiko Maehara. (2016) Prognostic value of BRAF V600E mutation and microsatellite instability in Japanese patients with sporadic colorectal cancer. Journal of Cancer Research and Clinical Oncology 143:1, pages 151-160.
Crossref
Min Jia, Lina Jansen, Viola Walter, Katrin Tagscherer, Wilfried Roth, Esther Herpel, Matthias Kloor, Hendrik Bläker, Jenny Chang-Claude, Hermann Brenner & Michael Hoffmeister. (2016) No association of CpG island methylator phenotype and colorectal cancer survival: population-based study. British Journal of Cancer 115:11, pages 1359-1366.
Crossref
Viola Walter, Lina Jansen, Michael Hoffmeister, Alexis Ulrich, Wilfried Roth, Hendrik Bläker, Jenny Chang-Claude & Hermann Brenner. (2016) Prognostic relevance of prediagnostic weight loss and overweight at diagnosis in patients with colorectal cancer. The American Journal of Clinical Nutrition 104:4, pages 1110-1120.
Crossref
Thomas Aparicio, Aziz Zaanan, Florence Mary, Pauline Afchain, Sylvain Manfredi & Thomas Ronald Jeffry Evans. (2016) Small Bowel Adenocarcinoma. Gastroenterology Clinics of North America 45:3, pages 447-457.
Crossref
M. ChomczykP. Czajka. (2016) K-RAS mutations in colorectal cancer in patients from Podlaskie region. Progress in Health Sciences 6:1, pages 70-77.
Crossref
Sun-Young Jun, Misung Kim, Mi Jin Gu, Young Kyung Bae, Hee-Kyung Chang, Eun Sun Jung, Kee-Taek Jang, Jihun Kim, Eunsil Yu, Dae Woon Eom & Seung-Mo Hong. (2016) Clinicopathologic and prognostic associations of KRAS and BRAF mutations in small intestinal adenocarcinoma. Modern Pathology 29:4, pages 402-415.
Crossref
Yosra Zaaimi, Thomas Aparicio, Pierre Laurent-Puig, Julien Taieb & Aziz Zaanan. (2016) Advanced small bowel adenocarcinoma: Molecular characteristics and therapeutic perspectives. Clinics and Research in Hepatology and Gastroenterology 40:2, pages 154-160.
Crossref
Prudence R Carr, Lina Jansen, Viola Walter, Matthias Kloor, Wilfried Roth, Hendrik Bläker, Jenny Chang-Claude, Hermann Brenner & Michael Hoffmeister. (2016) Associations of red and processed meat with survival after colorectal cancer and differences according to timing of dietary assessment. The American Journal of Clinical Nutrition 103:1, pages 192-200.
Crossref
Michael Hoffmeister, Lina Jansen, Anja Rudolph, Csaba Toth, Matthias Kloor, Wilfried Roth, Hendrik Bläker, Jenny Chang-Claude & Hermann Brenner. (2015) Statin Use and Survival After Colorectal Cancer: The Importance of Comprehensive Confounder Adjustment. JNCI: Journal of the National Cancer Institute 107:6.
Crossref
Min Jong Kim, Mi Jin Gu, Hee-Kyung Chang & Eunsil Yu. (2015) Loss of ARID1A expression is associated with poor prognosis in small intestinal carcinoma. Histopathology 66:4, pages 508-516.
Crossref
Reiko Kumagai. (2015) Mucinous phenotype and CD10 expression of primary adenocarcinoma of the small intestine. World Journal of Gastroenterology 21:9, pages 2700.
Crossref
Diana Cervantes-Madrid, Yair Romero & Alfonso Dueñas-González. (2015) Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy. BioMed Research International 2015, pages 1-13.
Crossref
Santosh Shenoy. (2014) Primary Small-Bowel Malignancy: Update in Tumor Biology, Markers, and Management Strategies. Journal of Gastrointestinal Cancer 45:4, pages 421-430.
Crossref
Sun-Young Jun, Dae Woon Eom, Hosub Park, Young Kyung Bae, Kee-Taek Jang, Eunsil Yu & Seung-Mo Hong. (2014) Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma. Modern Pathology 27:10, pages 1364-1374.
Crossref
Magali Svrcek, Gael Piton, Jacques Cosnes, Laurent Beaugerie, Severine Vermeire, Karel Geboes, Antoinette Lemoine, Pascale Cervera, Nizar El-Murr, Sylvie Dumont, Aurélie Scriva, Olivier Lascols, Sandro Ardizzone, Paolo Fociani, Guillaume Savoye, Florence Le Pessot, Gottfried Novacek, Fritz Wrba, Jean-Frédéric Colombel, Emmanuelle Leteurtre, Yoram Bouhnik, Dominique Cazals-Hatem, Guillaume Cadiot, Marie-Danièle Diebold, Jean-François Rahier, Monique Delos, Jean-François Fléjou & Franck Carbonnel. (2014) Small Bowel Adenocarcinomas Complicating Crohnʼs Disease Are Associated With Dysplasia. Inflammatory Bowel Diseases 20:9, pages 1584-1592.
Crossref
Thomas Aparicio, Aziz Zaanan, Magali Svrcek, Pierre Laurent-Puig, Nicolas Carrere, Sylvain Manfredi, Christophe Locher & Pauline Afchain. (2014) Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment. Digestive and Liver Disease 46:2, pages 97-104.
Crossref
T. Aparicio. (2014) Adénocarcinome de l’intestin grêleSmall bowel adenocarcinoma. Côlon & Rectum 8:1, pages 4-9.
Crossref
T Aparicio, M Svrcek, A Zaanan, E Beohou, A Laforest, P Afchain, Emmanuel Mitry, J Taieb, F Di Fiore, J-M Gornet, A Thirot-Bidault, I Sobhani, D Malka, T Lecomte, C Locher, F Bonnetain & P Laurent-Puig. (2013) Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. British Journal of Cancer 109:12, pages 3057-3066.
Crossref
Kanwal Raghav & Michael J. Overman. (2013) Small bowel adenocarcinomas—existing evidence and evolving paradigms. Nature Reviews Clinical Oncology 10:9, pages 534-544.
Crossref
Hee Jin Lee, Ok-Jun Lee, Kee-Taek Jang, Young Kyung Bae, Joon-Yong Chung, Dae Woon Eom, Joon Mee Kim, Eunsil Yu & Seung-Mo Hong. (2013) Combined Loss of E-cadherin and Aberrant β-Catenin Protein Expression Correlates With a Poor Prognosis for Small Intestinal Adenocarcinomas. American Journal of Clinical Pathology 139:2, pages 167-176.
Crossref
Tao Fu, Emmanouil P. Pappou, Angela A. Guzzetta, Jana Jeschke, Ruby Kwak, Pujan Dave, Craig M. Hooker, Richard Morgan, Stephen B. Baylin, Christine A. Iacobuzio-Donahue, Christopher L. Wolfgang & Nita Ahuja. (2012) CpG Island Methylator Phenotype–Positive Tumors in the Absence of MLH1 Methylation Constitute a Distinct Subset of Duodenal Adenocarcinomas and Are Associated with Poor Prognosis . Clinical Cancer Research 18:17, pages 4743-4752.
Crossref
Michael J. Overman, Chung-Yuan Hu, Scott Kopetz, James L. Abbruzzese, Robert A. Wolff & George J. Chang. (2011) A Population-Based Comparison of Adenocarcinoma of the Large and Small Intestine: Insights Into a Rare Disease. Annals of Surgical Oncology 19:5, pages 1439-1445.
Crossref
Kanwal Raghav, Matthew H. G. Katz & Michael J. Overman. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 441 451 .
J.C. Haan, T.E. Buffart, P.P. Eijk, M.A. van de Wiel, W.N. van Wieringen, P.D. Howdle, C.J.J. Mulder, C.J. van de Velde, P. Quirke, I.D. Nagtegaal, N.C.T. van Grieken, H. Grabsch, G.A. Meijer & B. Ylstra. (2012) Small bowel adenocarcinoma copy number profiles are more closely related to colorectal than to gastric cancers. Annals of Oncology 23:2, pages 367-374.
Crossref
Arne Warth, Matthias Kloor, Peter Schirmacher & Hendrik Bläker. (2011) Genetics and epigenetics of small bowel adenocarcinoma: the interactions of CIN, MSI, and CIMP. Modern Pathology 24:4, pages 564-570.
Crossref
Camille Laurent, Magali Svrcek, Jean-François Flejou, Marie-Pierre Chenard, Bernard Duclos, Jean-Noël Freund & Jean-Marie Reimund. (2011) Immunohistochemical expression of CDX2, β-catenin, and TP53 in inflammatory bowel disease-associated colorectal cancer. Inflammatory Bowel Diseases 17:1, pages 232-240.
Crossref
Begoña Diosdado, Tineke E. Buffart, Russell Watkins, Beatriz Carvalho, Bauke Ylstra, Marianne Tijssen, Anne S. Bolijn, Fraser Lewis, Karen Maude, Caroline Verbeke, Iris D. Nagtegaal, Heike Grabsch, Chris J.J. Mulder, Phil Quirke, Peter Howdle & Gerrit A. Meijer. (2010) High-Resolution Array Comparative Genomic Hybridization in Sporadic and Celiac Disease–Related Small Bowel Adenocarcinomas. Clinical Cancer Research 16:5, pages 1391-1401.
Crossref
Sara Michel, Matthias Kloor, Sandhya Singh, Georg Gdynia, Wilfried Roth, Magnus von Knebel Doeberitz, Peter Schirmacher & Hendrik Bläker. (2009) Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Molecular Carcinogenesis 49:2, pages 175-182.
Crossref
Patrick L. Wagner, Yao-Tseng Chen & Rhonda K. Yantiss. (2008) Immunohistochemical and Molecular Features of Sporadic and FAP-associated Duodenal Adenomas of the Ampullary and Nonampullary Mucosa. American Journal of Surgical Pathology 32:9, pages 1388-1395.
Crossref
K Breuhahn, S Singh, P Schirmacher & H Bläker. (2008) Large-scale N-terminal deletions but not point mutations stabilize β-catenin in small bowel carcinomas, suggesting divergent molecular pathways of small and large intestinal carcinogenesis. The Journal of Pathology 215:3, pages 300-307.
Crossref
Heike Immervoll, Dag Hoem, Kalaiarasy Kugarajh, Solrun J. Steine & Anders Molven. (2006) Molecular analysis of the EGFR-RAS-RAF pathway in pancreatic ductal adenocarcinomas: lack of mutations in the BRAF and EGFR genes. Virchows Archiv 448:6, pages 788-796.
Crossref
Megan Q Zhang, Zong-Ming E Chen & Hanlin L Wang. (2006) Immunohistochemical investigation of tumorigenic pathways in small intestinal adenocarcinoma: a comparison with colorectal adenocarcinoma. Modern Pathology 19:4, pages 573-580.
Crossref
David C. Hinselwood, Torveig W. Abrahamsen & Per O. Ekstrøm. (2005) BRAF mutation detection and identification by cycling temperature capillary electrophoresis. ELECTROPHORESIS 26:13, pages 2553-2561.
Crossref
O. Kutuk, A. Pedrech, P. Harrison & H. Basaga. (2005) Pramanicin induces apoptosis in Jurkat leukemia cells: A role for JNK, p38 and caspase activation. Apoptosis 10:3, pages 597-609.
Crossref
Julian R. F Walters. (2005) Recent findings in the cell and molecular biology of the small intestine. Current Opinion in Gastroenterology 21:2, pages 135-140.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.